RECRUITINGOBSERVATIONAL
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study
About This Trial
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age 65 years and older
Who Should NOT Join This Trial:
- known haematological condition (myelodysplasia, leukemia, cancer)
- inability to provide written willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age 65 years and older
Exclusion Criteria:
* known haematological condition (myelodysplasia, leukemia, cancer)
* inability to provide written informed consent
Treatments Being Tested
OTHER
Blood and bone marrow cell collection
Collection of blood and bone marrow
Locations (1)
Imelda Hospital
Bonheiden, België, Belgium